Kyverna Therapeutics Inc. (KYTX)
NASDAQ: KYTX
· Real-Time Price · USD
3.53
-0.01 (-0.28%)
At close: Aug 15, 2025, 3:59 PM
3.58
1.42%
After-hours: Aug 15, 2025, 06:09 PM EDT
Kyverna Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Cash & Equivalents | 53.44M | 56.87M | 96.62M | 104.66M | 131.62M | 224.29M | 34.65M | 22.97M | 224.29M | -51.32M | 37.73M |
Short-Term Investments | 158.24M | 185.78M | 189.36M | 216.92M | 214.62M | 145.51M | 22.9M | 54.31M | 145.51M | 102.64M | 13.59M |
Long-Term Investments | 551K | n/a | n/a | n/a | 574K | 570K | 565K | n/a | n/a | n/a | 554K |
Other Long-Term Assets | 4.05M | 4.2M | 5.26M | 2.44M | 1.21M | 1.17M | 3.36M | 2M | 1.74M | -51.32M | 678K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.65M | 5M | 4.62M | 3.79M | 2.59M | 5.69M | 3.12M | 2.14M | n/a | n/a | 1.93M |
Total Current Assets | 214.33M | 247.65M | 290.6M | 325.37M | 348.82M | 375.49M | 60.66M | 79.41M | 375.49M | 51.32M | 53.25M |
Property-Plant & Equipment | 7.58M | 8.8M | 10.66M | 11.38M | 12.51M | 12.75M | 10.61M | 11.07M | 12.75M | n/a | 12.44M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 12.18M | 13M | 15.92M | 13.82M | 14.29M | 14.5M | 14.53M | 13.08M | 14.5M | -51.32M | 13.67M |
Total Assets | 226.51M | 260.65M | 304.64M | 339.2M | 363.12M | 389.98M | 75.19M | 92.49M | 389.98M | n/a | 66.92M |
Account Payables | 9.92M | 8.47M | 4.62M | 9.93M | 4.86M | 7.45M | 4.36M | 3.02M | 7.45M | n/a | 1.45M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 9.06M | 8.11M | n/a | n/a | 7.66M |
Short-Term Debt | 3.58M | n/a | n/a | n/a | 3.87M | 3.72M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 21.32M | 3.08M | 4.88M | n/a | 8.15M | 5.62M | 9.77M | 4.81M | n/a | n/a | 6.82M |
Total Current Liabilities | 39.79M | 33.29M | 33.76M | 30.98M | 23.48M | 21.86M | 19.86M | 16.87M | 21.86M | n/a | 11.95M |
Long-Term Debt | 2.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 296K | n/a | n/a | 180.57M | 180.57M | n/a | n/a | 120.68M |
Total Long-Term Liabilities | 2.34M | 3.35M | 4.3M | 5.5M | 6.13M | 7.13M | 186.73M | 187.42M | 7.13M | n/a | 128.97M |
Total Liabilities | 42.13M | 36.65M | 38.06M | 36.49M | 29.61M | 28.99M | 206.59M | 204.29M | 28.99M | n/a | 140.92M |
Total Debt | 5.92M | 6.94M | 8.24M | 9.14M | 10M | 10.85M | 9.08M | 9.64M | 10.85M | n/a | 10.56M |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -350.24M | -308.15M | -263.52M | -226.03M | -191.54M | -162.74M | -136.04M | -115.38M | -162.74M | n/a | -75.68M |
Comprehensive Income | -20K | -1K | 105K | 153K | -37K | -1K | 4K | 5K | -1K | -74M | -26K |
Shareholders Equity | 184.38M | 224.01M | 266.59M | 302.71M | 333.51M | 360.99M | -131.4M | -111.81M | 360.99M | 46.68M | -74M |
Total Investments | 158.79M | 185.78M | 189.36M | 216.92M | 215.19M | 145.51M | 22.9M | 54.31M | 145.51M | 102.64M | 13.59M |